PMC

(A) Isolation procedure for primary human bronchial epithelial cells (B) Primary human bronchial epithelial cells cultured under submerged (left) and air-liquid interface conditions (right).

(A) IP-10 concentration in cell culture medium on day 4 and 8 p.i. as determined by ELISA (B) I-Tac concentration in cell culture medium on day 4 and 8 p.i. as determined by ELISA (n.s.: not significant, * p< 0.05; *** p< 0.001, two way ANOVA). Values shown are SEM values of quadruplicate infections.

Confocal microscopy immunofluorescence analysis of differentiated human bronchial epithelial cells. Figs A, B, C show XY planes, Figs D, E, F show XZ planes. (A, D) Cells were infected from the apical side with HAdV-B14p1 at a moi of 10 (TCID₅₀/cell), fixated 4 days p.i. and stained for HAdV in green (FITC conjugated antibody) and the desmoglein 2 (DSG2 receptor) in red (dsRed antibody), the nucleus was counterstained in blue (DAPI). (B, E) Differentiated human bronchial epithelial cells stained for DSG2 receptor in red (dsRed) and occludin (OCLN) a tight junction marker in green (FITC), nucleus was counterstained in blue (DAPI). (C, F) Differentiated human bronchial epithelial cells were stained for CAR receptor in red (dsRed) and the tight junction marker OCLN in green (FITC) and the nucleus in blue (DAPI).

(A) Intracellular HAdV genomes were quantified by qPCR at 1 h and 48 h p.i. (** p< 0.01; *** p< 0.001, unpaired t-test) (B) Release of infectious virus progeny at the apical side of the differentiated bronchial epithelial cell layer as determined by the TCID₅₀ method on day 1, 4, and 8 p.i. (** p< 0.01; *** p< 0.001, unpaired t-test). (C) Release of infectious virus progeny at the basal side of the differentiated bronchial epithelial cell layer as determined by the TCID₅₀ method on day 1, 4, and 8 p.i. (* p< 0.05; *** p< 0.001, unpaired t-test). The TCID₅₀ values in B and C are normalized against the input virus titers measured on day 1 p.i. and set to 1 x 10⁰ because the TCID₅₀ values measured on day 1 are probably remaining viral particles originating from the virus inoculum.